An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients

By Ersoy Mehmet A.   Noyan Aysin M.   Elbi Hayriye  

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 113-120

Adis International

Access to resources Recommend Favorite

Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial

By Rizkallah Élie   Stip Emmanuel   Zhornitsky Simon   Pampoulova Tania   Gendron Alain   Rompré Pierre-Paul   Chiasson Jean-Pierre   Potvin Stéphane  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2947-2951

Informa Healthcare

Access to resources Recommend Favorite

A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma

By Hamid Omid   Ilaria Robert   Garbe Claus   Wolter Pascal   Maio Michele   Hutson Thomas E.   Arance Ana   Lorigan Paul   Lee Jeeyun   Hauschild Axel   Mohr Peter   Hahka-Kemppinen Marjo   Kaiser Christopher   Turner P. Kellie   Conti Ilaria   Grob Jean-Jacques  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 2016-2024

Blackwell Publishing

Access to resources Recommend Favorite

Short-Term Efficacy and Safety of Leflunomide in the Treatment of Active Rheumatoid Arthritis in Everyday Clinical Use: Open-Label, Prospective Study

By Nguyen M.  

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite

An Open-label Study Investigating the Efficacy and Safety of 12 – 96 Weeks of Telmisartan Treatment in Patients with Hypertension

By Ingino C   Farsang C   Laucevicius A   Bergovec M  

The Journal of International Medical Research, Vol. 31, Iss. 6, 2003-11 ,pp. : 561-574

Field House Publishing

Access to resources Recommend Favorite